RE:Why? Early on Egrifta had a perception of being a "cosmetic" drug to help reduce belly fat. Some of that perception may still persist. It's up to TH to sell the other benefits to physicians. Some physicians may be reluctant to prescribe based on cost/benefit if they don't see the whole picture. More importantly I think TH needs to do a lot of direct to patient marketing as well. Sell the patients on the long term benefits and they will be asking their physicians to prescribe it.
palinc2000 wrote:
Knowing what we know from a lot of studies in the last year on the high incidence of Nash on people with Hiv Why dont doctors prescribe Egrifta to ALL Patients suffering from Lipo?Can FDA make such reccomandation?